The last earnings report, released on Feb 26, 2026, exceeded the consensus estimates by 0%.On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Paradigm Biopharmaceuticals Limited has completed 2 stock splits, with the recent split occurring on Nov 01, 2023.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on ASX (AUD).